ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEF

Yunlong Wang · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
atrial-fibrillationobesity
atrial fibrillation, heart failure with preserved ejection fraction (hfpef), tirzepatide, gip/glp-1 receptor agonist, obesity, hfpef, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 863868
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.